US 11702419
Heterocyclic compound and use thereof
granted A61KA61K9/2095A61K9/4833
Quick answer
US patent 11702419 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K9/2095, A61K9/4833, A61P, A61P25/00